Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Turoctocog alfa in Haemophilia A patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Turoctocog alfa (turoctocog alfa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2014-09-04